Zero ad trackers.We never sell your data.Healthcare professional?Clinician Resources

Immune Thrombocytopenia Clinical Trials Near Me

As of November 13, 2026, 86 Immune Thrombocytopenia clinical trials are recruiting now and 42 are not yet recruiting. In the US, 17 of them have at least 1 open site, across 33 states and Washington, DC. Enter your ZIP code below to see which are closest to you.

Also on Trial Friend:Immune Thrombocytopenia pageCompare treatmentsMatch Me

Trial Friend never receives or stores your ZIP code. Your browser looks up its location with a free map service.
Distance
Status
Ages
Phase
A study site. Select it to see its trials and get directions. Several sites close together. Select the number to zoom in.
+67 more

All 86 Immune Thrombocytopenia trials and their US sites

Enter your ZIP code above to sort them by how far their nearest open site is from you.

  1. A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
    Most sites in California, New York and North Carolina
    RecruitingPhase 3Ages 18+Takeda
    23US sites
    19 states
  2. A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
    Most sites in California, New York and North Carolina
    RecruitingPhase 3Ages 18+Takeda
    23US sites
    19 states
  3. A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)
    Most sites in Florida, Connecticut and New Jersey
    RecruitingPhase 2Ages 18+Novartis Pharmaceuticals
    23US sites
    17 states
  4. Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment
    Most sites in California, Massachusetts and Minnesota
    RecruitingPhase 3Ages 18+Sanofi
    18US sites
    12 states
  5. A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
    Most sites in California, North Carolina and Ohio
    RecruitingPhase 3Ages 18+argenx
    17US sites
    14 states
  6. A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
    Most sites in Texas, California and District of Columbia
    RecruitingPhase 1/2Ages 18+Eli Lilly and Company
    10US sites
    7 states
  7. Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders
    Most sites in Arizona, California and Colorado
    RecruitingPhase 2Ages 18+Incyte
    9US sites
    9 states
  8. Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
    Most sites in Texas, California and Maryland
    RecruitingPhase 1Ages 18-85Chugai Pharmaceutical
    7US sites
    6 states
  9. OM336 in Autoimmune Cytopenias
    Most sites in California, District of Columbia and Michigan
    RecruitingPhase 1Ages 18-75Lakefront Biotherapeutics West
    4US sites
    4 states
  10. A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)
    Most sites in California, New York and North Carolina
    RecruitingPhase 3Ages 18-70Kedrion S.p.A.
    3US sites
    3 states
  11. A Study of Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Previously Untreated Primary Immune Thrombocytopenia (ITP)
    Most sites in California, Illinois and Virginia
    RecruitingPhase 3Ages 18-100Amgen
    3US sites
    3 states
  12. Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease
    Most sites in Massachusetts, Minnesota and Nebraska
    RecruitingPhase 1/2Ages 18+CRISPR Therapeutics
    3US sites
    3 states
  13. Safety, Tolerability, and Efficacy of NVG-2089 in Participants With Immune Thrombocytopenia
    Most sites in District of Columbia, Massachusetts and North Carolina
    RecruitingPhase 2Ages 18-80Nuvig Therapeutics
    3US sites
    3 states
  14. A Study of Patients' Preferences for Primary Immune Thrombocytopenia Treatment
    Only in New Jersey
    RecruitingAges 18+Novartis Pharmaceuticals
    1US site
  15. Cognitive Dysfunction in Chronic and Persistent Immune Thrombocytopenia
    Only in Massachusetts
    RecruitingAges 18+Massachusetts General Hospital
    1US site
  16. A Clinical Study of NAD in the Treatment of Immune Thrombocytopenia
    RecruitingPhase 1/2Ages 18+Institute of Hematology & Blood Diseases Hospital, China
    No US site yet
  17. A Dose-escalation Study Followed by a Dose Optimal Study to Evaluate the Safety and Efficacy of CID-103 in Adults With Chronic Immune Thrombocytopenia
    RecruitingPhase 1/2Ages 18-65CASI pharmaceuticals
    No US site yet
  18. A Phase 1/2 Study of ESG206 in Patients With Primary Immune Thrombocytopenia
    RecruitingPhase 1/2Ages 18+Shanghai Escugen Biotechnology Co.
    No US site yet
  19. A Phase 1b/2a Study of Budoprutug in Subjects With Immune Thrombocytopenia (ITP)
    RecruitingPhase 1/2Ages 18+Climb Bio
    No US site yet
  20. A Phase Ib/II Clinical Trial of Multiple Doses of STSA-1301 Subcutaneous Injection in Healthy Subjects and Patients With Immune Thrombocytopenia (ITP)
    RecruitingPhase 1/2Ages 18-75Jiangsu BioJeTay Biotechnology Co.
    No US site yet
Get an email when Immune Thrombocytopenia trials change

New trials, status changes and new sites, straight from ClinicalTrials.gov. Unsubscribe anytime.

You'll get, for Immune Thrombocytopenia:
  • Trial Alerts, when a new trial opens or a trial changes
  • Disease Updates, FDA decisions and condition news, usually 1 or 2 emails a month
Turn either off anytime from the link in every email.
We never share your email. Unsubscribe anytime. Privacy policy · Check any health site

Who runs the Immune Thrombocytopenia trials in the US, and what stage they are in

Of the 17 Immune Thrombocytopenia trials with a US site, 6 are in Phase 3, the last stage before a company can ask the FDA for approval. Earlier Phase 1 or 2 tests of safety and dosing make up 9 of them. The remaining 2 have no drug phase, such as studies that follow people over time or test a device or a way of giving care. Companies run 16 of them, and a university, hospital, foundation or government group runs the other. The sponsors with the most are Novartis Pharmaceuticals (2) and Takeda (2). The most recently listed one first appeared on ClinicalTrials.gov on August 25, 2026.

Immune Thrombocytopenia trials in the US, state by state

None of the 17 Immune Thrombocytopenia trials with a US site lists children under 18 as eligible. A trial counts once in each state where it has an open site, and some trials accept both children and adults.

StateTrialsChildrenAdultsCities with the most
California11011Los Angeles (7), San Diego (2), Torrance (2), plus 6 more
Massachusetts808Boston (8), Danvers (1)
District of Columbia707Washington D.C. (7)
North Carolina707Greenville (5), Durham (4), Chapel Hill (1)
Texas707Houston (5), Austin (2), Fort Worth (1), plus 2 more
New York606The Bronx (5), New York (2), Albany (1), plus 1 more
Washington606Seattle (6)
Illinois505Peoria (3), Chicago (1), Hinsdale (1)
Minnesota505Rochester (4), Minneapolis (2)
Louisiana404New Orleans (3), Covington (1)
Show the other 24 states
New Jersey404East Brunswick (1), East Hanover (1), Little Silver (1), plus 2 more
Oregon404Portland (4)
Pennsylvania404Philadelphia (4), Pittsburgh (1)
Virginia404Norfolk (2), Fairfax (1), Fredericksburg (1)
Arizona303Chandler (1), Glendale (1), Phoenix (1)
Arkansas303Hot Springs (2), Fayetteville (1)
Connecticut303New Haven (3), Stamford (1)
Florida303Miami (2), Cooper City (1), Jacksonville (1), plus 2 more
Iowa303Iowa City (3)
Michigan303Ann Arbor (2), Detroit (1)
Missouri303Kansas City (3)
Ohio303Cleveland (3), Columbus (1)
Colorado202Aurora (1), Lone Tree (1)
Georgia202Atlanta (2)
Indiana202Indianapolis (2)
Kentucky202Louisville (2)
Maryland202Baltimore (1), Bethesda (1)
Utah202Ogden (1), Salt Lake City (1)
Wisconsin202Milwaukee (2)
Montana101Billings (1)
Nebraska101Omaha (1)
Oklahoma101Oklahoma City (1)
South Carolina101Greenville (1)
South Dakota101Sioux Falls (1)

US hospitals running the most Immune Thrombocytopenia trials

Centers that run trials for a rare condition often see more people with it than most clinics do, so this list can also help you find doctors who know Immune Thrombocytopenia.

  1. Montefiore Medical CenterThe Bronx, New York5 trials
  2. East Carolina UniversityGreenville, North Carolina4 trials
  3. Massachusetts General HospitalBoston, Massachusetts3 trials
  4. Oregon Health & Science UniversityPortland, Oregon3 trials
  5. Baylor College of MedicineHouston, Texas2 trials
  6. Beth Israel Deaconess Medical CenterBoston, Massachusetts2 trials
  7. Cleveland ClinicCleveland, Ohio2 trials
  8. Duke University HospitalDurham, North Carolina2 trials
  9. Duke University Medical CenterDurham, North Carolina2 trials
  10. Emory UniversityAtlanta, Georgia2 trials

Help getting to an Immune Thrombocytopenia trial far from home

Ask the study team whether the trial pays back travel, parking and hotel costs, because many sponsors do. The FDA's guidance on paying research volunteers says paying back these costs does not count as pressuring someone to join.

These nonprofits also help patients reach care, and each one sets its own rules.

Mercy Medical Angels
Pays for gas cards, ground rides and airline tickets anywhere in the US, and it lists clinical trials as a reason to travel. Household income at or below 300% of the federal poverty guidelines, and usually a trip of 50 miles or more each way.
Air Charity Network
Volunteer pilots in all 50 states fly patients for free in small private planes, and members also fly people taking part in clinical trials. You must be able to walk and sit upright for the flight, show financial need and have a backup plan if weather cancels it.
Healthcare Hospitality Network
Keeps a map of hospitality houses near hospitals, and most member houses charge little or nothing to patients and families. Each house sets its own rules, so check with the house near your study site.

Program details were checked on each program's website on October 24, 2026.

Questions about finding an Immune Thrombocytopenia trial near you

Are there Immune Thrombocytopenia clinical trials near me?

As of November 13, 2026, 86 Immune Thrombocytopenia clinical trials are recruiting now and 42 are not yet recruiting. In the US, 17 of them have at least 1 open site, across 33 states and Washington, DC. Enter your ZIP code on this page to rank every one of them by the distance to its closest open site, with the sites shown on a map.

Which states have Immune Thrombocytopenia clinical trial sites?

Recruiting Immune Thrombocytopenia trials list open sites in 33 states and Washington, DC. California, Massachusetts and District of Columbia have the most, and the table on this page lists every state.

Are there Immune Thrombocytopenia trials for children near me?

None of the 17 Immune Thrombocytopenia trials with a US site lists children under 18 as eligible. Each trial sets its own age limits, so check the ages listed on a trial before you contact it.

Who pays for travel to an Immune Thrombocytopenia clinical trial?

Many trial sponsors pay back travel, parking and hotel costs, so ask the study team before you rule out a far-away site. The FDA's guidance says paying back these costs does not count as pressuring someone to join. Charities such as Mercy Medical Angels and Air Charity Network can also help with rides and flights.

What if there is no Immune Thrombocytopenia trial near me?

Some trials send staff to your home or use a local lab, so fewer visits happen at the study site. You can also sign up on this page to get an email when an Immune Thrombocytopenia trial opens a new site or changes status.

How is the distance to a trial site measured?

Distances are straight-line miles from the center of your ZIP code to each study site's listed location, not driving distance. Your browser looks up the ZIP code's coordinates with a free map service, Zippopotam.us, and the ZIP code is never sent to or stored by Trial Friend.

FDA-approved for Immune Thrombocytopenia: Alvaiz (eltrombopag choline), Doptelet (avatrombopag), Nplate (romiplostim), Promacta (eltrombopag), Tavalisse (fostamatinib), Wayrilz (rilzabrutinib), Corticosteroids (prednisone, prednisolone, methylprednisolone, dexamethasone, hydrocortisone), Immune globulin (immune globulin (human)).

Source: ClinicalTrials.gov, trials with status Recruiting or Not yet recruiting. Refreshed every 6 hours; counts as of November 13, 2026. Sites that ClinicalTrials.gov lists as closed or withdrawn are left out. Children means the trial's age group includes people under 18.